Vaxart Inc (VXRT)
6.02
+0.10 +1.69%
NASDAQ
Mar 5, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 4.046M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.35 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -32.22M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -3.89K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 708.96M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 131.27 |
| PE Ratio | -- |
| Price to Book Value | 5.745 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow (Quarterly) | -11.67M |
| Return on Equity | Upgrade |
View All VXRT News
News
-
WireHeadlineTime (ET)
-
Yahoo03/06 08:00
-
Yahoo03/06 06:50
-
Yahoo03/06 06:00
-
Yahoo03/05 10:11
-
Yahoo03/05 06:00
-
Globe Newswire03/04 16:01
-
MT Newswires03/04 09:11
-
SA Breaking News03/03 09:49
-
Yahoo03/02 14:30
-
Yahoo03/02 04:23
-
Yahoo03/01 06:04
-
Yahoo02/26 15:26
-
SA Breaking News02/25 17:42
-
MT Newswires02/25 16:09
-
MT Newswires02/25 16:09
-
Globe Newswire02/25 16:01
-
Yahoo02/25 16:01
-
Globe Newswire02/24 16:01
-
Yahoo02/24 07:47
-
Yahoo02/15 06:30
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 05/12/2021 | Earnings | Vaxart Inc First Quarter Earnings Results for 2021 |
| 02/25/2021 | Earnings | Vaxart Inc Fourth Quarter Earnings Results for 2020 |
| 02/25/2021 | Misc | Vaxart Inc Annual Report for 2020 |
| 11/12/2020 | Earnings | Vaxart Inc Third Quarter Earnings Results for 2020 |
| 08/06/2020 | Earnings | Vaxart Inc Second Quarter Earnings Results for 2020 |
| 06/08/2020 | Misc | Vaxart Inc Annual General Meeting for 2019 |
| 05/12/2020 | Earnings | Vaxart Inc First Quarter Earnings Results for 2020 |
| 03/19/2020 | Earnings | Vaxart Inc Fourth Quarter Earnings Results for 2019 |
| 03/19/2020 | Misc | Vaxart Inc Annual Report for 2019 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.vaxart.com
- Investor Relations URL: http://investors.aviragentherapeutics.com/index.cfm
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Blend
- Next Earnings Release: May. 12, 2021
- Last Earnings Release: Feb. 25, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Nov. 09, 2012
- Description: Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 6.02 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- VXRT Tweets Stocktwits
Advertisement
